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ABSTRACT: Disintegration performance was measured by analysing both water ingress and tablet swelling of pure microcrystalline
cellulose (MCC) and in mixture with croscarmellose sodium using terahertz pulsed imaging (TPI). Tablets made from pure MCC with
porosities of 10% and 15% showed similar swelling and transport kinetics: within the first 15 s, tablets had swollen by up to 33% of
their original thickness and water had fully penetrated the tablet following Darcy flow kinetics. In contrast, MCC tablets with a porosity
of 5% exhibited much slower transport kinetics, with swelling to only 17% of their original thickness and full water penetration reached
after 100 s, dominated by case II transport kinetics. The effect of adding superdisintegrant to the formulation and varying the temperature
of the dissolution medium between 20°C and 37°C on the swelling and transport process was quantified. We have demonstrated that
TPI can be used to non-invasively analyse the complex disintegration kinetics of formulations that take place on timescales of seconds
and is a promising tool to better understand the effect of dosage form microstructure on its performance. By relating immediate-release
formulations to mathematical models used to describe controlled release formulations, it becomes possible to use this data for formulation
design. C© 2015 The Authors. Journal of Pharmaceutical Sciences published by Wiley Periodicals, Inc. and the American Pharmacists
Association J Pharm Sci 104:3440–3450, 2015
Keywords: terahertz pulsed imaging; structure–transport relationship; porosity; swelling; solid dosage forms; polymeric drug delivery
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INTRODUCTION
In order to ensure a drug is readily available for absorption in as
short a time as possible, the formulation design of immediate-
release oral tablets is focussed on achieving rapid disintegra-
tion and dissolution. Immediate-release tablets are designed to
fully disintegrate within a set period, normally within 2.5 min
and not longer than 10 min.1,2 This can be particularly impor-
tant where a rapid onset of action is required, for example for
analgesics,3 or to achieve suitable bioavailability of a poorly
soluble drug substance, that is to maximise dissolution by in-
creasing the contact time with body fluids.1 In these cases,
the formulation can be a critical factor in meeting the qual-
ity target product profile. Immediate-release formulations typ-
ically employ hydrophilic and hygroscopic excipients that facil-
itate disintegration by promoting media ingress and swelling
of the tablet. Disintegrants are obviously important com-
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ponents of the formulation to establish these rapid release
properties, however, other excipients may have an impact.
The most widely used superdisintegrants are croscarmellose
sodium (CCS), sodium starch glycolate and crospovidone. Rela-
tively small amounts of superdisintegrants are added to tablet
formulations, typically between 2% and 5% byweight,3 which is
enough to influence the disintegration performance in the drug
delivery systems via liquid transport enhancement by rapid
swelling as well as gel formation.4–6
Microcrystalline cellulose7 (MCC) is a widely used flowa-
bility aid and diluent that can be pre-granulated or directly
compacted.8 MCC is highly hygroscopic.9,10 In addition to the ef-
fect of disintegrants, MCC also enhances liquid transport into a
tabletmatrix, accelerating both diffusion and capillary action.11
The choice of superdisintegrant may be based on demonstra-
tion of compatibility with the drug substance and prior famil-
iarity rather than a rational selection based on achieving opti-
mum disintegration for the system under development.5 Other
excipients such as lactose, mannitol, magnesium stearate and
silica amongst other compounds are commonly added to the
formulation to produce dosage forms which achieve desirable
tablet properties in terms of fill weight and flowability.12–15
The chemistry of the excipients strongly affects disintegra-
tion performance, but other environmental andmicrostructural
factors must be considered16: the tortuosity, porosity and pore
size distribution will impact the rate of penetration of the
dissolution solvent as well as the initial release of the active
pharmaceutical ingredient (API).16 The hydration times are of
critical importance in controlling the rate of disintegration of
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immediate-release formulations. An estimate of tablet poros-
ity can be made based on calculation of the volume of a tablet
and the weighted average of the true density of the formula-
tion components. Alternatively, more sophisticated methods to
measure the porosity of tablets directly are using liquid or gas
intrusion.10,17
The analysis of immediate-release formulations before and
during the disintegration process is essential in understanding
drug release mechanisms and improving the efficiency of drug
release.
It is well known that the porosity of tablets directly affects
the rate at which water and other bodily fluids enter and prop-
agate through the tablet matrix.16 In addition to the standard
porosimetry techniques, we have recently demonstrated that
the bulk porosity of the tablets can be measured using ter-
ahertz time-domain spectroscopy (THz-TDS).18,19 If the thick-
ness of the tablet is known, the technique can be used to extract
the porosity of the tablet following a fast non-invasive trans-
missionmeasurement.18 X-raymicrocomputed tomography can
also be used to extract the porosity of the tablets, but is lim-
ited by the pixel size of the image to pores of approximately
>2 :m.20 The porosity is of importance in predicting how liq-
uids penetrate into the tablet matrix and the predictions can
be validated by experimental analysis of solvent penetration.21
One typical method to resolve the penetration process is the
use of magnetic resonance imaging (MRI).22–26 Hydration of
tablets is measured by mapping the position of 1H-nuclei asso-
ciated with mobile water, thus mapping out the ingress of wa-
ter into the tablet matrix non-destructively. We have recently
demonstrated that terahertz pulsed imaging (TPI) can also be
used in this context.27 This method exploits the transparency
of polymers at terahertz frequencies as well as the differences
between the refractive index of polymers and solvents. Solvents
typically have a higher refractive index and this change of re-
fractive index provides the contrast between the solvent and
polymer28 that can be used to track the water front into the
tablet matrix.28
Traditionally, dissolution and disintegration performance is
based on the release of API into the dissolution medium. Typ-
ical techniques which have been used to analyse the release of
API, include UV–Vis/HPLC,29,30 MRI,22–26 thermo gravimetric
analysis,31,32 infrared spectroscopy and infrared imaging33–36
amongst other techniques. These techniques have been applied
to controlled release formulations to understand the release
kinetics of the API and the tablet swelling kinetics,37 as well
as to provide insight into how tablet formulation, geometries
and dissolution kinetics affect API release during formulation
development.
The types of transport which significantly contribute to the
solvent transport into tablet matrices are capillary action and
diffusion.1,38 Diffusion theory is used to directly relate swelling
and transport in these systems37 by modelling either Fick-
ian transport, which is driven by the concentration gradient
across the tablet,37 and case II transport, which is solvent pen-
etration dependent on an activity gradient such as swelling.39
Diffusion theory has been used to relate swelling and solvent
ingress into the tablet and thus understand tablet dissolution
performance.25,39–41 A common method of linking the swelling
to the API release is by using a power law.
y = ktm (1)
where y is the displacement of the API through the tablet ma-
trix, k is a fitting parameter, t is the time and m is the power
law constant that is characteristic of the transport processes
observed.37 This value is dependent on the geometry of the
tablet.37 For cylindrical tablets, m values of approximately 0.5
correspond to Fickian transport and values of approximately
1.0 relate to case II transport. This is a very simplistic transport
model, which relates the velocity front of a solvent within the
tablet to transport kinetics. More complex models such as the
Higuchi model introduce concentration terms.42 Models have
been developed and are used to describe API release in partic-
ular in controlled release formulations. The power law is one of
the most commonly used mathematical models to describe API
release in controlled release systems.
When considering transport in porous media, a major trans-
port mechanism which should be considered is flow controlled
by a gradient in capillary pressure throughout the tablet sys-
tem, typically referred to as Darcy flow.43 A commonly used
solution to describe Darcy flow behaviour is referred to as the
Washburn equation (see also Supplementary Information)44
y =
√
(rcos2t
2:
(2)
where y is the displacement of the solvent propagating through
the solvent, ( is the surface tension, 2 is the contact angle, t
is the penetration time and : is the dynamic viscosity.45 Work
has been carried out to relate the Washburn equation with
swelling to understand how the two processes interlink.46–48 In
this study, we will use Darcy flow to model the liquid ingress
into the porous media. It is better suited in this context com-
pared with Fickian diffusion models as there is no inherent
concentration gradient present within the pores when describ-
ing immediate release formulations where solvent penetration
is studied into dry tablets and there is almost exclusively air
occupying the pore space within the tablet.
Here, we use TPI to analyse the ingress of water into MCC-
based immediate-release formulations, by taking advantage of
the high time resolution of this technique and then applying the
mathematical models discussed by Siepmann and Peppas37 and
Costa and Sousa Lobo,42 normally applied to controlled release
formulations, to immediate-release formulation, in order to re-
solve the impact of different excipients on the disintegration
performance of immediate-release formulations. The formula-
tions assessed in this study represent simplified systems, which
were prepared to closely resemble commercial formulations, to
provide an insight into the key characteristics during water
ingress and disintegration.
MATERIALS AND METHODS
Materials
The samples analysed in this study were flat-faced tablet com-
pactsmade from 100%wtMCC (Avicel R© PH-102; FMCBioPoly-
mers, Philadelphia, Pennsylvania), a commercial grade of MCC
that is typically used in direct compression formulations. In
addition, tablet compacts containing both MCC and CCS (Ac-
Di-Sol R©; FMC BioPolymers) were prepared. CCS is one of the
most widely used commercial superdisintegrants. Tablets were
compressed to a thickness of 1.5 mm and diameter of 10 mm,
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with nominal calculated porosities of 0.05, 0.10, 0.15 and 0.40.
Three tablet formulations will be discussed in this paper; 100%
wtMCC, MCC 95%wt and CCS 5% as well as MCC 98%wt and
CCS 2%. No lubricant was added to the formulation or applied
directly to the punches/die during compression.
Porosity Measurements
Porositymeasurementswere carried using a THz-TD spectrom-
eter in transmissionmode on pureMCC tablets, using the setup
described by Parrot et al.49. The beam waist at the focus of the
tablet is 6 mm in diameter and therefore porosity measure-
ments using THz-TDS represent the central 36% of the tablet
volume. Using the technique described by Bawuah et al.18, the
refractive index (nt) of the tablets is extracted and from this the
permittivity (geff) of the tablets can be calculated, where geff =
nt2. The method is calibrated by two known refractive indices
at known porosities. Given the relative permittivity of air (na
= 1, ga = 1), it is possible to calculate the relative permittivity
of MCC (gb):
f a
ga − geff
ga + 2geff + f b
gb − geff
gb + 2geff = 0 (3)
where geff is the permittivity of the tablet, fa is the fraction of
the tablet taken up by air (void fraction) and fb is the fraction
of the tablet taken up by MCC (solid fraction). The relative
permittivity of MCC can then be used to calculate the porosities
of MCC tablets with different porosities using the obtained
refractive indices.
gb = 3geff(
1− (f − (1− f )) ((geff − 1) / (1+ 2geff )
) − 2geff (4)
Equation 4 is solved for f , which is the tablet porosity. Density
measurements of the solid matrix of the tablets were obtained
using the Accupyc 1330 Pycnometer (Micrometrics, Norcross,
Georgia). Initially samples were weighed and then placed into
a 1 cm3 cup. The sample chamber was pressurised to 10 bar
with helium and this was repeated 30 times, after which a
density reading for the solid matrix was recorded (solid density
Dp). Using these data the density of the void space within the
tablet was determined and the porosity was calculated. These
values were then used as known porosities to compare with the
terahertz time-domain measurements, as well as an input for
the known tablet porosity fb.
Porosities were also calculated by dividing the mass of the
tablet by its volume, resulting in bulk density (Db) of the tablet
(Db = m/v). The bulk density is then divided by the weighted
average of the true density of each excipient within the formu-
lation (Dt) to produce the solid fraction of the tablet, subtracting
this value from unity will then result in the total porosity of the
tablet (f).
Compression of Tablet Compacts
Flat-faced, round tablet compacts of 10mm diameter were com-
pressed using a compaction simulator (Phoenix Calibrations,
Phoenix, Arizona). The device was instrumented such that it
can measure the forces of compaction throughout the compres-
sion event. Powder was loaded into the dies using a hopper
and volumetric filling was performed to ensure tablets were
achieved with target porosities of 5%, 10% and 15%. A sec-
ondary method of die fill was also studied where the die was
d
p
p
Figure 1. Typical compaction profile measured by the compaction
simulator, where (a) is the compaction force profile of both the upper
and lower punch and (b) is the punch displacement. This is an example
of a profile producing a pure MCC tablet of 10% porosity.
manually filled, producing pureMCC tablets with 10% and 40%
porosities. Tablets were compressed over a 10 s period using a
uniaxial compression profile, Figure 1.
Disintegration Testing
Disintegration tests were carried out using a disintegration
tester (DT) (Agilent Technologies, Santa Clara, California).
Tablets are hydrated using water at 37°C, and experiments
are carried out and timed until tablets fully disintegrate (no
visible residue of the tablet remain on the screen of the test
apparatus or adhere to the lower surface of the discs).
Transport Analysis using TPI
Transport and swelling kinetics were measured using a mod-
ified TPI imaga 2000 (Teraview Ltd., Cambridge, UK) as out-
lined previously in more detail by Yassin et al.27. In this study,
a flow cell design was developed to achieve more reproducible
measurements (Fig. 2).
The cell was developed to ensure that water only contacts
tablets from a single axial surface (this will be referred to as
the back surface in the remainder of the paper); hence, this
technique is assessing the one-dimensional transport of water
into the tablet matrix. The water flow was set to 140 mL/min.
The cell was designed such that the front surface of the tablet
sits at a distance of 7 mm from the terahertz optics, which is
the focal length of the TPI Imaga 2000 optics (Fig. 3). In our ex-
periments, 15 measurements are being acquired per second. In
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Figure 2. Newly developed flow cell, where panel (a) shows the ex-
terior of the flow cell and panel (b) shows an internal cross-section at
the centre of the cell, showing the flow geometry. 1 is the sample holder
with a sealant to ensure only one-dimensional transport through the
axial surface of the tablet occurs, 2 is the tablet sample, 3 is a polyethy-
lene window, 4 is a bed of 0.5 cm glass ballotini beads and 5 marks the
position of the tablet in the flow cell. Panel (c) is the schematic repre-
sentation of the flow loop; T1 the water tank and heat exchanger, P1
the peristaltic pump, D1 is a flow dampener, F1 is the flow cell and S1
is TPI sensor.
order to remove noise, five waveforms are co-averaged resulting
in an effective sampling rate of three waveforms per second.
The TPI measurements can resolve the ingress of water as
it enters the tablet matrix and the subsequent swelling of the
matrix itself. The way in which water transport is measured
is by exploiting the transparency of the polymers to terahertz
radiation and monitoring the changes in refractive index be-
tween the tablet and water. Initially, the tablet has a refractive
index between that of the solid matrix material and air (n =
1.0), which is occupying the pores of the material as described
in Eq. 3. As water starts to wet the tablet matrix, it displaces
the air in the pores and increases the refractive index of the
Figure 3. Schematic diagram describing how terahertz radiation in-
teracts with the experimental setup and sample. nair is the refractive
index of air, ntab is the average refractive index of the tablet and nsol is
the refractive index of water.
material, water having a higher refractive index (n = 2.4)50
than the solid matrix. This change in refractive index provides
contrast, which makes it possible to monitor the ingress of the
water into the tablet. Each time the terahertz pulse encoun-
ters a change in refractive index a portion of the pulse will be
reflected back to the emitter.
The analysis of the results follows the method outlined by
Yassin et al.27, with a modification to account for the changes
due to the new flow cell as an additional reflection from the
newly introduced PE window needs to be considered during
the analysis. To ensure all artefacts are removed, an additional
averaging step is introduced. Each full waveform contains 2048
points. The window of interest typically spans from points 600
to points 1800, which corresponds to an optical time delay of
0–3.5 mm in air. Box widths of 50 points were averaged on each
waveform (p¯t50) and each of these boxes are averaged over the
total experiment (x¯50). This value is then subtracted from each
point on the waveform, at the region of interest (600–1800), on
each individual waveform (pt). This process can be shown in
Eq. 5 below:
DenoisedData = pt − x¯50 = pt −
∑t
i=ts i
nts
(5)
where (t) is the experimental run time, (ts) is the time between
each time point and (nts ) is the number of time steps.
RESULTS AND DISCUSSION
Demonstration of the New Flow System
For a proof-of-principle experiment samples of 100% wt MCC
with porosities of approximately 10 ± 5% and 40 ± 5% were
prepared by direct compression following manual filling of the
die without hopper. Waterfall plots were produced to visualise
the transformations qualitatively in each tablet over the exper-
imental run time. Two examples are shown in Figure 4.
Liquid ingress is apparent in both samples (t3 front high-
lighted in red). It is clear that in the 40% porosity sample, the
transport of water through the tablet matrix is much faster: the
penetration of water through the entire tablet takes about 3 s as
opposed to approximately 13 s in the 10% porosity tablets of the
same thickness. An interesting result is observed in that rather
than a single peak multiple penetration fronts are observed in
the tablet of 40% porosity. This is caused by the simultaneous
collapse in structure during the hydration process, leading to
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Figure 4. (a) Deconvolved time-domain waveforms showing the hy-
dration of a MCC tablet of 10% porosity (each line is offset by 0.01 a.u.);
and (b) 40% porosity MCC tablet (each line is offset by 0.005 a.u.). t1
corresponds to the front surface of the tablet, t2 corresponds to the back
surface of the tablet, t3 corresponds to the hydration front and t4 cor-
responds to the formation of cracks within the tablet matrix due to the
strain caused by the hydration.
cracks on both the tablet surface and within the tablet matrix
that can be detected by the additional reflections. It also leads
to larger volumes of water being able to enter the tablet matrix.
Swelling is observed in both the 10% and 40% porosity
tablets (Fig. 5a). Not only do the 40% porosity tablets start
to fracture internally upon water ingress but they also undergo
strong expansion, swelling by up to 1.5 mm at the front surface.
The tablets typically break apart after approximately 15 s. In
contrast, the 10% porosity MCC tablets expand by only 0.2 mm
at the front surface. They largely retain their shape through-
out the experimental procedure and do not break within 200 s.
This can be explained by the difference in magnitude of the
applied compaction forces that act on the MCC powder dur-
ing the tableting process: to produce tablets with 10% poros-
ity, approximately 7.0 kN of force are applied, whereas only
0.4 kN are applied to achieve 40% porosity. The 40% poros-
ity tablets represent an extreme system, which would not be
used in final formulations, but it does provide an insight into
how large porosities can impact tablet formulations. It is well
known that the strength of the sinter bridges formed between
the particles are controlled by the compaction force, where a
higher compaction force produces stronger sinter bridges.51 As
the MCC is being hydrated some particles begin to adsorb wa-
ter given MCC’s hygroscopicity. This process, which is inde-
pendent of temperature,52 weakens the interparticular bonds
and results in swelling of the tablet. This swelling together
with the relatively large volume of water available in the 40%
Figure 5. (a) Average swelling profile of tablet samples of pure MCC
of 10% porosity (red circles) and 40% porosity (black triangles) at a
water temperature of 20°C. (b) Corresponding transport kinetics based
on the position of the water front within the pure MCC expressed as
the displacement of the penetration front relative to the back surface of
the tablet. The shading marks the SD (n = 3). The error bar represents
the average disintegration time and SD (n = 3). The tablets with 10%
porosity do not disintegrate.
porosity sample facilitates breaking of the sinter bridges. A
secondary process which further advances swelling is the slow
relaxation of the axial stress due to the compaction process,
originating from the elastic deformation of the MCC powders
within the tablet matrix.53 This relaxation will be accelerated
during hydration.54 The relative strength of the intraparticu-
lar bonds affects the time it takes for the tablet to fully dis-
integrate: tablets with a porosity of 40% break down in 18 ±
5 s, whereas the 10% porosity tablets do not disintegrate over
the timescales of the experiment. It is clear that towards the
end of the swelling process in the 40% porosity tablets that the
reproducibility becomes poor and this is because the individ-
ual tablets are breaking at different time points. The rate of
swelling affects the penetration kinetics (Fig. 5b). It is clear
that in the 40% porosity tablets there is a more linear profile in
water transport into the tablet compared with that of the 10%
porosity tablets. This process can be quantified by applying the
power law Eq. 1 to the position of the water front over time
Figure 6.
Effect of Porosity and Temperature on MCC Disintegration
In order to investigate the disintegration process inmore detail,
a second set of MCC samples was prepared with total porosi-
ties spanning a smaller range (5%, 10% and 15%). In addition,
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Figure 6. Experimental transport kinetics fitted using the power law,
where black dots represent data obtained experimentally and the red
lines are the power law fit. (a) 10% porosity MCC tablet; and (b) 40%
porosity tablets. Both samples were compacted following manual filling
of the dies.
the measurements were performed at two water temperatures
(20°C and 37°C) to further explore the effect of the dissolution
medium on the disintegration process. Prior to the TPI mea-
surements the bulk porosities of the samples were determined
using helium pycometry and THz-TDS (Table 1).
The reproducibility of the results, in particular regarding
the movement of the penetration fronts of water into the sam-
ple, is improved in this second set of samples compared to the
previous set when assessing tablets compacted to 10% porosity
Table 1. Porosity Measurements of the MCC Tablets Obtained using
Helium Pycnometry and THz-TDS
Sample R(cm3) fp fTHz fcalc
5P1 0.116 0.045 N/A 0.058
5P2 0.116 0.042 N/A 0.058
10P1 0.107 0.100 0.103 0.106
10P2 0.106 0.109 0.105 0.104
15P1 0.104 0.141 0.148 0.157
15P2 0.104 0.144 0.142 0.152
 is the solid volume calculated using helium pycnometry (the SD between
10 repeat measurements for each individual sample was better than 0.001 cm3
in all samples tested); fp is the resulting porosity calculated based on the volume
measured by pycnometry and the tablet mass; fTHz is the porosity calculated
using THz-TDS based on the sample thickness and refractive index; and fcalc is
the calculated porosity of each sample as outlined in the introduction. 5P refers
to samples of 5% nominal porosity, 10P to 10% nominal porosity and 15P to 15%
nominal porosity.
Figure 7. (a) Swelling and (b) transport kinetics, in pureMCC tablets
at a water temperature of 20°C. The background shading corresponds
to the SD between three, five and three tablets, respectively, for the
samples of 15%, 10% and 5% porosity, respectively. For clarity only
every 10th data point is plotted except for the inset of (b) where all data
points are shown. The tablets do not disintegrate over the duration of
the experiment.
(Fig. 7): there is less variation in the swelling behaviour which
results in a lower SD between the measurements. The only
difference between the samples is the method used to fill the
die with MCC powder prior to compaction. The initial samples
were prepared by manual die filling, whereas the second set of
samples were prepared using automated hopper filling of the
die. It is interesting to note that it appears that the manual fill-
ing process caused sufficient variation in the microstructure of
the tablets that caused a significant change in the penetration
kinetics.
When comparing the three different sets of samples, the rate
of swelling and solvent penetration was found to correlate with
the porosity of the tablets. Transport of water from the back
surface of the tablet to its front in the 15% porosity tablets oc-
curs on average within 19 s. In both the 15% and 10% porosity
tablets, rapid swelling of the tablet matrix is observed within
30 s. During this period, the tablet matrix expands by up to 50%
of its original thickness and full liquid penetration is achieved.
The tablet expansion continues more gradually for the remain-
der of the experiment. The rate of swelling reduces after ap-
proximately 25 s for both the 10% and 15% porosity tablets
(Fig. 7). This change of rate can be attributed to the satura-
tion of the MCC particles with water within the tablet matrix.
Upon saturation, the rate of uptake of water begins to decrease
resulting in a slowdown of the rate of swelling.52 Within the
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Figure 8. (a) Swelling kinetics and (b) transport kinetics in MCC
at a water temperature of 37°C. The shading in the background of
each plot corresponds to the SD between five, six and three tablets for
the samples of 15%, 10% and 5% porosity, respectively. For clarity only
every 10th data point is plotted except for the inset of (b) where all data
points are shown. The tablets do not disintegrate over the duration of
the experiment.
largely laminar flow regime that the tablets are exposed to at
their back the samples remain intact throughout this process
without fully disintegrating even following their complete hy-
dration. In contrast, the 5% porosity tablets exhibit quite a
different hydration behaviour. Overall the transport kinetics in
the 5% porosity samples are slower and more linear. It takes on
average 148 s for the water to propagate from the back surface
of the tablet to its front. In terms of the swelling behaviour, two
phases can be resolved: gradual swelling the first 125 s; this
is then followed by a slightly more rapid expansion phase. The
magnitude of swelling in the 5% porosity tablets is of similar
magnitude to that of the higher porosity tablets. In the case of
the 5%, 10% and 15% porosity tablets, the tablet matrix held
its shape throughout the experiment.
In order to investigate the influence of the water tempera-
ture on the disintegration process, the experiments have been
repeated with warmer water at approximately body tempera-
ture (Fig. 8).
As the water temperature is increased to 37°C, the swelling
and transport is consistently faster compared with a temper-
ature of 20°C. This is not surprising as the kinetic energy in
water increases with temperature. Overall the swelling profiles
look similar in shape to the experiments carried out at the lower
temperature except for the swelling behaviour in the 5% poros-
ity tablets, which appears to be less linear at the higher water
temperature. As was the case for the tablets measured at 20°C,
the tablet matrices do not disintegrate during the experiment
at 37°C.
The results from DT show no correlation between porosity
and disintegration time: MCC tablets were found to disinte-
grate within 333 ± 30 s at 5% porosity, 597 ± 0 s at 10%
porosity and 37 ± 3 s at 15% porosity. The results highlight
that in the case of pure MCC tablets, the disintegration test,
as outlined by the pharmacopoeias, is providing information on
the mechanical stability of the tablets rather than their dis-
integration performance due to interaction with solvent. Here,
the mechanical shear applied to the tablets as well as the tablet
collisions with the wall of the DT lead to disintegration and it is
the physical properties of the tablets such as plasticity, brittle-
ness and elasticity which are being tested for rather than the
changes in microstructure induced by wetting with solvent.
Effect of Disintegrant on MCC Matrix Disintegration
In order to investigate the effect of adding superdisintegrant to
the formulation, samples of 95% MCC with 5% CCS and 98%
MCC with 2% CCS were prepared. The tablets had an overall
porosity of 10% and TPI disintegration testing was performed
at 20°C and 37°C (Fig. 9).
By adding a superdisintegrant to the formulation, the tablet
disintegration dynamics changed dramatically. In contrast to
the pure MCC tablets with porosities of 5%, 10% and 15%,
the tablets containing the disintegrant break down consistently
and water transport into the tablet matrices is accelerated. At
20°C, liquid transport through the entire tablet takes place
over a 6 s period in tablets containing 5% CCS. During this
time, the tablets swell by up to 20% of their initial thickness
and all tablets were found to break apart within a total of
7 s. When the temperature is increased to 37°C, the process
slows down significantly. Liquid transport takes place on aver-
age over 38 s, accompanied by swelling to approximately 17%
of its original thickness. Break down of the tablets is observed
during the hydration process, in 6 ± 1 s at 20°C and within 38
± 19 s at 37°C. When the concentration of the disintegrant is
reduced to 2% there is a significant change in the tablet disin-
tegration kinetics. At 20°C, liquid uptake slows down, which is
reflected in an apparent change in transport mechanism and
disintegration times fall to 65 ± 7 s. At temperatures of 37°C,
the disintegration kinetics is similar to samples containing 5%
CCS with total disintegration occurring within 41 ± 5 s.
As expected, the hydration process is consistently faster in
the samples that contain CCS compared with the pure MCC
tablets. This can be explained by its ability to swell up to
300% of its volume, which allows it to break apart the tablet
when evenly mixed into the tablet matrix.5 In contrast to the
plain MCC tablets, where faster hydration was observed at
higher temperature, the increase in temperature lead to slower
disintegration characteristics once CCS was added to the for-
mulation. This can be explained by the fact that CCS forms
a gel when in contact with water. Hydrogel formation is fa-
cilitated at increased temperatures55 and the disintegration
process hence slows down upon hydration at 37°C. Upon gel for-
mation, the gel immediately fills the macropores and interpar-
ticulate voids thus slowing down further water ingress as well
acting as a binder because of the increased viscosity of the gel
compared with the water. In addition the hydrogel acts as a bar-
rier to further liquid ingress because of its hydrophobic nature,
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Figure 9. (a) Swelling kinetics and (b) corresponding transport kinetics in tablets of 10% porosity containing a formulation of 95% MCC and
5% croscarmellose. (c) Swelling kinetics and (d) transport kinetics of a formulation of 98% MCC and 2% CCS. The shading in the background
marks the SD of five repeat experiments. The x-error bar represents the average disintegration time and its SD (n = 5) for samples containing
5% CCS and 2% CCS. For clarity only every 10th data point is plotted.
which also slows down the disintegration process.55 At 20°C
hydrogel formation in CCS occurs at a lower rate resulting
in much faster penetration of water into the tablet matrix.
The samples containing 2% CCS exhibit slower disintegra-
tion kinetics compared to the samples containing 5% CCS.
The reduced amount of CCS within the tablet decreases the
effect from the swelling of the CCS particles. We have ob-
served a marked change in disintegration kinetics as a re-
sult of a relatively small change in concentration of CCS and
we believe this is a significant result given that a concen-
tration of 0.5%–5% CCS is the typical range used in tablet
formulations.
In the case of the tablets containing disintegrant, the DT
results correlated well with the results obtained using the TPI
at 37°C where tablets containing 5% CCS broke apart in 30 ±
4 s and tablets containing 2% CCS disintegrate in 26 ± 3 s.
This can be explained by the fact that for the tablets contain-
ing disintegrant, the rapid swelling action of the disintegrant
dominates the disintegration process, whereas the MCC alone
does not disintegrate without external mechanical activation
which is absent in the TPI measurements.
Summary of the TPI Hydration Analysis
Typically, the pharmacopoeias require that the DT should be
carried out at 37°C, yet our experiments show that there is a
large difference in disintegration kinetics between 20°C and
37°C. Given that patients might swallow tablets with a cold
cup of water (which will be far below 37°C and often even be-
low 20°C), understanding tablet disintegration at temperatures
other than 37°C is of key importance.
Using the power law equation introduced earlier, the trans-
port kinetics of all the water transport properties of the tablets
studied in this paper can be summarised by their exponent m
(Fig. 10). The power law is widely used to describe both API
release and liquid penetration into polymer systems by relat-
ing the position of the propagating component with time.28,37
The advantage of applying this simple model to the TPI data
in order to resolve the transport kinetics is that it does not re-
quire the knowledge of the water concentration,37 opposed to
both Fick’s law of diffusion56 and the Higuchi model.37
As briefly discussed in the Introduction, Darcy’s law appears
to be the most suitable model to describe the initial water pen-
etration process into these systems compared with the Fick’s
law of diffusion as there is no concentration gradient of wa-
ter throughout the porous network in our samples. Here, it is
assumed that a gradient in capillary action will be the gradi-
ent which regulates liquid penetration. A model of the liquid
ingress has been derived (Eq. 6), which provides a solution to
Darcy’s law that mathematically follows the same form as the
power law from Fick’s diffusion.
L =
√
2kt
"
(6)
Here, L is the displacement of the liquid ingress front, k is the
permeation rate constant, t is the time of displacement and "
is the swelling ratio as derived in the attached Supplementary
Information. This result shows that the liquid displacement in
the Darcy flow regime will propagate as a function of the square
root of time and hence can be approximated using a power law,
y = ktm, when m = 0.5.
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Figure 10. Schematic representation showing a classification of the type of transport observed in each sample studied based on the m values
extracted from the power law fit of the respective transport kinetics measurements. Samples marked by * were prepared by manual die filling
prior to compaction; all other samples were filled using a hopper. f refers to porosity.
Using a fit of the power law, y = ktm, to the experimental
data the exponent m can be determined, where values of 0.5
indicate Darcy flow, 0.75 anomalous transport and 1.0 case II
transport.41 Darcy flow is dependent on a gradient of capil-
lary pressure from low to high concentration.39 Case II trans-
port is driven by an activity gradient, which is the effect of
swelling on the transport of solvent into the tablet, due to in-
hibited transport from either increased tortuosity, the forma-
tion of hydrogels, reduced porosity of the tablet or enhanced
swelling behaviour amongst other effects.39 These are standard
physical phenomena which can be considered to cause case II
transport.39 Anomalous transport shows both Darcy flow and
case II characteristics.
The m values obtained for the 10% porosity samples ranged
from 0.54 ± 0.02, 0.50 ± 0.04 and 0.73 ± 0.09 depending on
how they were prepared and at what temperature the experi-
ment was carried out. These values indicate that at the lower
temperature Darcy flow dominates but when the temperature
is increased to 37°C the transport mechanism becomes anoma-
lous and therefore gains case II character: both the magnitude
and the rate of swelling increase with temperature, which in
turn accelerate the concomitant water transport resulting in
transport kinetics that are dependent on both concentration
and activity gradients.
For the samples of 5% total porosity, m values are found
that correspond to anomalous transport with strong case II
character. This is caused by the lack of sufficiently large (and
connected) pores within the tablet matrices which severely hin-
ders liquid transport. Therefore, the relative rate of swelling is
greater in comparison with the rate of solvent penetration and
thus the swelling process starts to govern the transport kinetics
of the liquid ingress.
In contrast, in the 15% porosity tablets the large amount
of pore space within the tablet matrices makes liquid trans-
port very quick relative to the swelling and therefore Darcy
flow is expected to dominate, which is confirmed by the mea-
sured m values. However, when the porosity is increased to
40%, swelling becomes so rapid that it significantly affects the
liquid transport and hence swelling and water ingress occur
on similar time scales. Consequently both concentration and
activity gradients again affect the transport through the tablet.
It is important to note in this context that the particle size of
the formulation has a direct impact on the pore size distribu-
tion within the resulting tablet matrix after compaction, where
small particles result in smaller pores and larger particles typi-
cally produces tablets with larger pore size distributions.57 Pore
size distributions and porosity are also inversely proportional
to the compaction force. This change in pore size distribution
has a direct impact on the transport kinetics of the solvent
through the tablet matrices with slower solvent transport in
tablets of lower porosity and with smaller pore size.1,58 This
effect can be resolved in the pure MCC samples in this study
where the 5% porosity samples exhibited considerable slower
transport kinetics compared with the higher porosity ones.
By adding superdisintegrant to the tablet matrices, both the
swelling and transport kinetics change dramatically. At both
temperatures swelling is significant but at the higher tempera-
ture the swelling process is considerably slowed down because
of the increased gel formation, which results in Darcy domi-
nated flow character. At temperatures below the gel formation
the swelling is more rapid and hence case II characteristics
dominate themass transport. These observations correlate well
with previous data.55
Case II kinetics is broadly defined as a transport process
which is influenced by an activity gradient. We found that a
number of different factors can result in such behaviour of a
tablet formulation: (1) as a result of hindered transport because
of the lack of available pore volume, for example as highlighted
in the 5% porosity samples; (2) as a result of rapid swelling
caused by the addition of a superdisintegrant such as CCS;
or (3) because of the weaker compacts produced by the lower
compaction forces as shown in the 40% porosity samples.
CONCLUSIONS
Transport and swelling kinetics were measured in MCC over
a range of porosities and multi component tablets of MCC and
CCS. We have developed a method to quantitatively measure
themagnitude of swelling and resolve the velocity front of water
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penetrating the tablet on timescales suitable for the analysis
of rapid release formulations.
Using this setup, it was possible to investigate the effect of
subtle differences in the compaction process on the disintegra-
tion performance as well as effects of temperature and porosity.
Manual die filling showed a significant effect on the disintegra-
tion behaviour of the resulting tablets and this could be resolved
using the TPI technique.
We showed that a number of different factors can drastically
affect the disintegration behaviour of an immediate-release
tablet formulation: (1) the available pore volume and its role in
tablet hydration; (2) the effect of rapid swelling caused by the
addition of a superdisintegrant such as CCS; (3) the strength
of the interparticular sinter bridges; and (4) the temperature
of the dissolution medium. Any one of these factors can easily
double or halve the disintegration timescales. We believe that
by taking into account these physicochemical characteristics it
is possible to improve the formulation design for immediate-
release tablets and achieve a more consistent and robust per-
formance of such formulations over a wide range of conditions.
It is clear that TPI can be used to analyse immediate-release
tablets in a manner which was previously possible only in con-
trolled release tablets. Taking advantage of the high time res-
olution that can be achieved by TPI makes it possible to anal-
yse liquid ingress, tablet swelling, microstructural changes and
disintegration times quantitatively. This makes it possible to
start resolving how different formulation components and mi-
crostructures affect the tablet disintegration and might allow
for a more rational design of immediate-release formulations
in the future.
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